The influence of various therapeutic regimens on early clinical and laboratory response and outcome of children with secondary hemophagocytic lymphohistiocytosis

INTRODUCTION: Secondary hemophagocytic lymphohistiocytosis (sHLH) is a life-threatening syndrome of severe hyperinflammation which is often triggered by infection or autoimmune disease (macrophage activation syndrome – MAS). The aim of our study was to assess the frequency of sHLH/MAS in children tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Buda, Piotr, Gietka, Piotr, Książyk, Janusz B., Machaczka, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778409/
https://www.ncbi.nlm.nih.gov/pubmed/29379544
http://dx.doi.org/10.5114/aoms.2015.56325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778409/
https://www.ncbi.nlm.nih.gov/pubmed/29379544
http://dx.doi.org/10.5114/aoms.2015.56325

Ejemplares similares